Expert Opinion on Investigational Drugs
Title Abbreviation
Expert Opin Investig Drugs
Electronic ISSN
1744-7658
Readership
Managers, Pharmacologists, Scientists
Scope
Expert Opinion on Investigational Drugs [ISSN 1354-3784]; [e-ISSN 1744-7658] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers on drugs in preclinical and early-stage clinical development, providing expert opinion on the scope for future development. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
Expert Opinion on Investigational Drugs address the needs of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.
The Editors welcome: Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies. Drug Evaluations reviewing the clinical and pharmacological data on a particular drug. Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Taylor & Francis, Inc. - UK
To see more details about Expert Opinion on Investigational Drugs,
Subscribe Now!
Impact Factor
JCR Categories/Rank
Circulation
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines